INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
03 · Corporate insiders

Form 4 filings

Officers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.

Form 4 transactions

Cluster activity · 60d

Most active filers

Companies with the most Form 4 filings
Data sources
SEC Form 44h ago
House PTR4h ago
SEC 13F4h ago
Robinhood Chain4h ago

Most active filers · 30d

  1. 01Kurtz George0B / 217S · 10 late217 trades$54.77M
  2. 02SPSaba Capital Management, L.P.66B / 21S · 14 late87 trades$28.40M
  3. 03ATAdair Kathleen Theresa52B / 0S · 52 late52 trades$18K
  4. 04AJAllaire Jeremy0B / 50S50 trades$4.26M
  5. 05CFCheng Chi Fung0B / 42S42 trades$15.33M
  6. 06RARothblatt Martine A0B / 33S33 trades$5.50M
  7. 07RJRubinstein Julie0B / 32S32 trades$5.55M
  8. 08LBLeach Bryan0B / 30S30 trades$7.97M
  9. 09AOAtay Oguzhan0B / 30S30 trades$7.55M
  10. 10JDJenkins William D Jr0B / 30S30 trades$13.38M

Form 4 transactions

66,876 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
9
ME
Main Jennifer ElizabethDirector
CTEVClaritev Corp
Grant or award
A—
3,113 sh
Oct 15, 2026Oct 19, 2026
Page 180 of 1672
← PrevNext →
traded Oct 15, 2026
+4d
SEC Form 4

Evidence

9
VJ
Vogelstein R JacobDirector
IAMIambic Therapeutics, Inc.
Derivative conversion
C—
2.00M sh
Oct 16, 2026Oct 19, 2026
traded Oct 16, 2026
+3dSEC Form 4

Evidence

9
MP
McClaskey James PaulChief Accounting Officer
INSGINSEEGO CORP.
Tax withholding
F$1,930
465 sh
Oct 15, 2026Oct 19, 2026
traded Oct 15, 2026
+4dSEC Form 4

Evidence

9
TN
Tolia Nirav NDirector, CEO and President, 10% Owner
NXDRNextdoor Holdings, Inc.
Option exercise
M—
45.1K sh
Oct 15, 2026Oct 19, 2026
traded Oct 15, 2026
+4dSEC Form 4

Evidence

9
TS
Thomsen Joel S.TRUSTEE
NONENONESterling Real Estate Trust
Grant or award
A$12K
479 sh
Oct 15, 2026Oct 19, 2026
traded Oct 15, 2026
+4dSEC Form 4

Evidence

9
VJ
Vogelstein R JacobDirector
IAMIambic Therapeutics, Inc.
Derivative conversion
C—
122.7K sh
Oct 16, 2026Oct 19, 2026
traded Oct 16, 2026
+3dSEC Form 4

Evidence

9
LC
Lisowski CraigPresident of Products
NXDRNextdoor Holdings, Inc.
Option exercise
M—
178.6K sh
Oct 15, 2026Oct 19, 2026
traded Oct 15, 2026
+4dSEC Form 4

Evidence

9
HF
Han FeiChief Financial Officer
DFDVDeFi Development Corp.
Tax withholding
F$11K
2,803 sh
Oct 17, 2026Oct 19, 2026
traded Oct 17, 2026
+2dSEC Form 4

Evidence

9
Catalio Capital Management, LP10% Owner
IAMIambic Therapeutics, Inc.
Derivative conversion
C—
731.2K sh
Oct 16, 2026Oct 19, 2026
traded Oct 16, 2026
+3dSEC Form 4

Evidence

9
VJ
Vogelstein R JacobDirector
IAMIambic Therapeutics, Inc.
Derivative conversion
C—
742.5K sh
Oct 16, 2026Oct 19, 2026
traded Oct 16, 2026
+3dSEC Form 4

Evidence

9
RL
Rachlin Evan LockwoodDirector
IAMIambic Therapeutics, Inc.
Derivative conversion
C—
1.46M sh
Oct 16, 2026Oct 19, 2026
traded Oct 16, 2026
+3dSEC Form 4

Evidence

9
CG
Chandrasena GillianSVP, Chief HR Officer
MMEDMiniMed Group, Inc.
Grant or award
A—
1,800 sh
Oct 15, 2026Oct 19, 2026
traded Oct 15, 2026
+4dSEC Form 4

Evidence

9
LC
Lisowski CraigPresident of Products
NXDRNextdoor Holdings, Inc.
Option exercise
M—
41.4K sh
Oct 15, 2026Oct 19, 2026
traded Oct 15, 2026
+4dSEC Form 4

Evidence

9
Kurtz GeorgeDirector, PRESIDENT AND CEO
CRWDCrowdStrike Holdings, Inc.
Open-market sale · 10b5-1 plan
SELL$378K
1,608 sh
Oct 16, 2026Oct 19, 2026
traded Oct 16, 2026
+3dSEC Form 4

Evidence

9
KM
Kiernan MichaelChief Revenue Officer
NXDRNextdoor Holdings, Inc.
Option exercise
M—
27.6K sh
Oct 15, 2026Oct 19, 2026
traded Oct 15, 2026
+4dSEC Form 4

Evidence

9
VJ
Vogelstein R JacobDirector
IAMIambic Therapeutics, Inc.
Derivative conversion
C—
1.46M sh
Oct 16, 2026Oct 19, 2026
traded Oct 16, 2026
+3dSEC Form 4

Evidence

9
JP
Johnson Christine ProcopioSVP, CSO
KWRQUAKER CHEMICAL CORP
Grant or award
A—
504 sh
Oct 15, 2026Oct 19, 2026
traded Oct 15, 2026
+4dSEC Form 4

Evidence

9
VJ
Vogelstein R JacobDirector
IAMIambic Therapeutics, Inc.
Derivative conversion
C—
1.46M sh
Oct 16, 2026Oct 19, 2026
traded Oct 16, 2026
+3dSEC Form 4

Evidence

9
Catalio Capital Management, LP10% Owner
IAMIambic Therapeutics, Inc.
Derivative conversion
C—
1.46M sh
Oct 16, 2026Oct 19, 2026
traded Oct 16, 2026
+3dSEC Form 4

Evidence

9
Catalio Capital Management, LP10% Owner
IAMIambic Therapeutics, Inc.
Derivative conversion
C—
742.5K sh
Oct 16, 2026Oct 19, 2026
traded Oct 16, 2026
+3dSEC Form 4

Evidence

9
Catalio Capital Management, LP10% Owner
IAMIambic Therapeutics, Inc.
Derivative conversion
C—
1.14M sh
Oct 16, 2026Oct 19, 2026
traded Oct 16, 2026
+3dSEC Form 4

Evidence

9
VJ
Vogelstein R JacobDirector
IAMIambic Therapeutics, Inc.
Derivative conversion
C—
742.5K sh
Oct 16, 2026Oct 19, 2026
traded Oct 16, 2026
+3dSEC Form 4

Evidence

9
RL
Rachlin Evan LockwoodDirector
IAMIambic Therapeutics, Inc.
Derivative conversion
C—
410.8K sh
Oct 16, 2026Oct 19, 2026
traded Oct 16, 2026
+3dSEC Form 4

Evidence

9
KM
Kiernan MichaelChief Revenue Officer
NXDRNextdoor Holdings, Inc.
Option exercise
M—
27.6K sh
Oct 15, 2026Oct 19, 2026
traded Oct 15, 2026
+4dSEC Form 4

Evidence

9
CB
Crowley Kyle BradfordDirector
PUMPProPetro Holding Corp.
Grant or award
A—
11.8K sh
Oct 16, 2026Oct 19, 2026
traded Oct 16, 2026
+3dSEC Form 4

Evidence

9
CE
Carlsen ElyseCAO
RSGREPUBLIC SERVICES, INC.
Grant or award
A$161
1 sh
Oct 15, 2026Oct 19, 2026
traded Oct 15, 2026
+4dSEC Form 4

Evidence

9
PM
Polovitz MarkTRUSTEE
NONENONESterling Real Estate Trust
Grant or award
A$923
38 sh
Oct 15, 2026Oct 19, 2026
traded Oct 15, 2026
+4dSEC Form 4

Evidence

9
GH
Grayson Bruns HDirector
RBBNRibbon Communications Inc.
Grant or award
A—
19.2K sh
Oct 15, 2026Oct 19, 2026
traded Oct 15, 2026
+4dSEC Form 4

Evidence

9
KM
Kiernan MichaelChief Revenue Officer
NXDRNextdoor Holdings, Inc.
Option exercise
M—
65.0K sh
Oct 15, 2026Oct 19, 2026
traded Oct 15, 2026
+4dSEC Form 4

Evidence

9
GM
Gilday Michael M.Director
CACICACI INTERNATIONAL INC /DE/
Grant or award
A—
328 sh
Oct 15, 2026Oct 19, 2026
traded Oct 15, 2026
+4dSEC Form 4

Evidence

9
WA
Woronoff Michael ADirector
AREALEXANDRIA REAL ESTATE EQUITIES, INC.
Grant or award
A—
500 sh
Oct 15, 2026Oct 19, 2026
traded Oct 15, 2026
+4dSEC Form 4

Evidence

9
BS
Blouin Ann ScottDirector
ENSGENSIGN GROUP, INC
Grant or award
A—
600 sh
Oct 15, 2026Oct 19, 2026
traded Oct 15, 2026
+4dSEC Form 4

Evidence

9
TS
Thomsen Joel S.TRUSTEE
NONENONESterling Real Estate Trust
Grant or award
A$1,594
66 sh
Oct 15, 2026Oct 19, 2026
traded Oct 15, 2026
+4dSEC Form 4

Evidence

9
Catalio Capital Management, LP10% Owner
IAMIambic Therapeutics, Inc.
Derivative conversion
C—
2.00M sh
Oct 16, 2026Oct 19, 2026
traded Oct 16, 2026
+3dSEC Form 4

Evidence

9
BF
Baumgartner FlorianEVP and CEO, Vista
CMPRCIMPRESS plc
Option exercise
M—
1,025 sh
Oct 15, 2026Oct 19, 2026
traded Oct 15, 2026
+4dSEC Form 4

Evidence

9
RL
Rachlin Evan LockwoodDirector
IAMIambic Therapeutics, Inc.
Derivative conversion
C—
57.8K sh
Oct 16, 2026Oct 19, 2026
traded Oct 16, 2026
+3dSEC Form 4

Evidence

9
SN
Scruggs Todd N.SVP, CFO
HPHelmerich & Payne, Inc.
Tax withholding
F$18K
481 sh
Oct 15, 2026Oct 19, 2026
traded Oct 15, 2026
+4dSEC Form 4

Evidence

8
CN
Chylak Robert NestorSenior Vice President
KLICKULICKE & SOFFA INDUSTRIES INC
Tax withholding
F$81K
1,029 sh
Oct 16, 2026Oct 19, 2026
traded Oct 16, 2026
+3dSEC Form 4

Evidence

8
LC
Lisowski CraigPresident of Products
NXDRNextdoor Holdings, Inc.
Tax withholding
F$55K
21.0K sh
Oct 15, 2026Oct 19, 2026
traded Oct 15, 2026
+4dSEC Form 4

Evidence

8
LC
Lisowski CraigPresident of Products
NXDRNextdoor Holdings, Inc.
Tax withholding
F$96K
36.9K sh
Oct 15, 2026Oct 19, 2026
traded Oct 15, 2026
+4dSEC Form 4

Evidence

Cluster activity · 60d

  1. BUYTSMTAIWAN SEMICONDUCTOR MANUFACTURING CO LTDNov 5 – Nov 631 insiders$417K
  2. SELLDRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
  3. BUYMTDRMatador Resources CoNov 5 – Nov 99 insiders$642K
  4. SELLFERGFerguson Enterprises Inc. /DE/Oct 12 – Oct 167 insiders$7.38M
  5. SELLSYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
  6. BUYUPBDUPBOUND GROUP, INC.Nov 2 – Nov 37 insiders$1.34M
  7. SELLIBEXIBEX LtdSep 14 – Sep 166 insiders$2.01M
  8. SELLARQQArqit Quantum Inc.Oct 2 – Oct 136 insiders$369K